Regenerating the Cardiovascular System Through Cell Reprogramming; Current Approaches and a Look Into the Future
Cardiovascular disease (CVD), despite the advances of the medical field, remains one of the leading causes of mortality worldwide. Discovering novel treatments based on cell therapy or drugs is critical, and induced pluripotent stem cells (iPS Cells) technology has made it possible to design extensi...
Main Authors: | Marianna Tsifaki, Sophia Kelaini, Rachel Caines, Chunbo Yang, Andriana Margariti |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcvm.2018.00109/full |
Similar Items
-
Looking into the Black Box: Insights into the Mechanisms of Somatic Cell Reprogramming
by: Jeffrey L. Wrana, et al.
Published: (2011-01-01) -
Comparison of reprogramming factor targets reveals both species-specific and conserved mechanisms in early iPSC reprogramming
by: Kai Fu, et al.
Published: (2018-12-01) -
Induced pluripotent stem (iPS) cells and somatic cardiac regeneration — An exploratory bioinformatic analysis
by: Robert Chen, et al.
Published: (2016-04-01) -
A stochastic model of epigenetic dynamics in somatic cell reprogramming
by: Max eFloettmann, et al.
Published: (2012-06-01) -
Integration-free mRNA reprogramming of human fibroblasts: The study of aging upon reprogramming
by: Rohanisarvestani, Leili
Published: (2015)